Malignancies Associated with Pediatric HIV Infection: Long Term Survivors on Highly Active Anti Retroviral Therapy(HAART) 760

被引：0
|
作者：
Ninad Desai
Scott T Miller
Edward Handelsman
Senih Fikrig
Sreedhar P Rao
Hermann Mendez
机构：
[1] Brooklyn Pediatric AIDS Network,
[2] SUNY Health Science Center at Brooklyn,undefined
[3] Div. of Pediatric Hematology / Oncology,undefined
[4] SUNY Health Science Center at Brooklyn,undefined
[5] Div of Ped. Immunology,undefined
[6] SUNY Health Science Center at Brooklyn,undefined
来源：
Pediatric Research | 1998年 / 43卷 / Suppl 4期
关键词：
D O I：
10.1203/00006450-199804001-00781
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：132 / 132
相关论文
共 50 条
  • [31] Predictors of immunologic failure in treatment naive HIV infected patients who start highly active anti-retroviral therapy (HAART)
    Tesema, A.
    Kumie, A.
    Showa-Amare, A.
    G-Yohannes, A.
    Gabrekidan, T.
    HIV MEDICINE, 2012, 13 : 31 - 31
  • [32] Outcome of HIV associated tuberculosis in the era of highly active antiretroviral therapy (HAART)
    Dheda, K
    Lampe, F
    Lipman, M
    Johnson, M
    THORAX, 2002, 57
  • [33] Nutritional status and effect of highly active anti-retroviral therapy (HAART) on selected trace elements in people living with HIV in Ghana
    Saka, Regina
    Domfeh, Emmanuel A.
    Hayford, Frank E. A.
    Asante, Matilda
    Amoah, Albert G. B.
    Asare, George A.
    Wiredu, Edwin K.
    SCIENTIFIC AFRICAN, 2023, 19
  • [34] Hepatotoxicity associated with highly active antiretroviral therapy (HAART) in HIV/AIDS patients
    Dragovic, G
    Jevtovic, D
    DRUG SAFETY, 2005, 28 (10) : 951 - 952
  • [35] Safety and immunogenicity of an HIV-1 tat toxoid vaccine in HIV-1 infected volunteers on highly active anti retroviral therapy (HAART)
    Frachette, MJ
    RETROVIRUSES OF HUMAN AIDS AND RELATED ANIMAL DISEASES, 2003, : 179 - 181
  • [36] T-cell re-population in HIV-infected children on highly active anti-retroviral therapy (HAART)
    King, DJS
    Gotch, FM
    Larsson-Sciard, EL
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2001, 125 (03): : 447 - 454
  • [37] Resolution of disseminated molluscum contagiosum with Highly Active Anti-Retroviral Therapy (HAART) in patients with AIDS
    Calista, D
    Boschini, A
    Landi, G
    EUROPEAN JOURNAL OF DERMATOLOGY, 1999, 9 (03) : 211 - 213
  • [38] Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy
    Mark E. Sharkey
    Ian Teo
    Thomas Greenough
    Natalia Sharova
    Katherine Luzuriaga
    John L. Sullivan
    R. Pat Bucy
    Leondios G. Kostrikis
    Ashley Haase
    Claire Veryard
    Raul E. Davaro
    Sarah H. Cheeseman
    Jennifer S. Daly
    Carol Bova
    Richard T. Ellison
    Brian Mady
    Kwan Kew Lai
    Graeme Moyle
    Mark Nelson
    Brian Gazzard
    Sunil Shaunak
    Mario Stevenson
    Nature Medicine, 2000, 6 : 76 - 81
  • [39] Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy
    Sharkey, ME
    Teo, I
    Greenough, T
    Sharova, N
    Luzuriaga, K
    Sullivan, JL
    Bucy, RP
    Kostrikis, LG
    Haase, A
    Veryard, C
    Davaro, RE
    Cheeseman, SH
    Daly, JS
    Bova, C
    Ellison, RT
    Mady, B
    Lai, KK
    Moyle, G
    Nelson, M
    Gazzard, B
    Shaunak, S
    Stevenson, M
    NATURE MEDICINE, 2000, 6 (01) : 76 - 81
  • [40] Long term results of Stanford V regimen and highly active antiretroviral therapy (HAART) in 59 patients (pts) with HD and HIV infection (HD-HIV)
    Vaccher, E.
    Spina, M.
    Gabarre, J.
    Fasan, M.
    Re, A.
    Schiantarelli, C.
    Talamini, R.
    Tirelli, U.
    ANNALS OF ONCOLOGY, 2006, 17 : XI56 - XI56
12345